Take a look inside this month's issue.
In this issue of Contemporary OB/GYN, we cover a wide range of topics for ob-gyns, including:
For a medical device start-up to be successful, it needs a talented team, decisive implementation, and adequate funding. Without resources for prototype development, patent filing, regulatory work, and more, the best ideas will die on the vine because running out of funds is a common reason for failure.
In an exclusive interview, Nash Moawad, MD, MS, FACOG, FACS, discussed the recent implementation of the Essentials of Minimally Invasive Gynecologic Surgery (EMIGS) training program, which helps physicians provide the best care and ensure optimal safety for their patients.
Breaking down barriers through patient selection, new devices, and the latest techniques.
Research in Menopause connects history of physical/sexual abuse, financial instability with worse menopausal symptoms and overall wellbeing at midlife.
In a recent study, it was found that access to contraceptive services declined during the COVID-19 pandemic.
Practicing clinicians were highly impressed with an interactive, virtual intrauterine device (IUD) training model that increased their comfort with IUD placement and removal, according to a study published in the journal Family Medicine.
Prenatal exposure to industrial air pollutants increases risk of adverse birth outcomes in infants.
In a recent study, participants who had received a COVID-19 vaccine saw an average increase in menstrual cycle length of less than 1 day.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More